Medable appoints Mike Kourey to board of directors

US clinical trials platform Medable has announced the appointment of Mike Kourey to its board of directors.

The enterprise software veteran and Dialpad CFO has more than 25 years’ experience in helping hyper-growth companies scale.

Kourey oversaw five successful IPOs as CFO, venture partner or audit chair, including Okta, RingCentral, Aruba Networks, Riverbed and Polycom.

This depth of experience will drive ‘tremendous value’ for Medable’s stakeholders and patients worldwide, the company said.

Medable CEO and co-founder, Dr. Michelle Longmire, said:

“The Medable SaaS platform enables leading life sciences companies to drive adoption of decentralised clinical trials at an enterprise level.

“As a member of Medable’s board of directors, Mike’s know-how in developing scaled SaaS companies will be invaluable as we look to further empower our partners and deliver unsurpassed customer and patient success around the world.”

Kourey is the latest addition to Medable’s growing employee roster.

The company has expanded from 100 staff in early 2020 to more than 600 today.

The company brought in a new capital infusion of $304 million in Series D funding last October to reach a valuation of $2.1 billion.

Kourey said:

“Medable is changing the game when it comes to clinical trials and drug development – focusing on equitable, patient-first decentralised and hybrid studies designed to measure the true impact of therapies in real-world settings.

“I am thrilled to join Michelle and Medable’s brilliant team of powerhouse leaders as they drive Medable to unprecedented heights in the health tech industry.”

The digital platform streamlines design, recruitment, retention and data quality for decentralised trials, replacing siloed systems with integrated digital tools, data and interfaces.

The technology connects patients, sites and clinical trial teams to improve patient access, experience and outcomes.